why choose us

First received: November 22, 2023

Clinical Trial: A Phase 1 Study of Cytokine-induced Memory-like (CIML) NK Cells With Venetoclax as Consolidation Therapy in AML

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Acute Myeloid Leukemia

Study Type: INTERVENTIONAL


Official Title: Study of Cytokine-induced Memory-like (CIML) NK Cells With Venetoclax as Consolidation Therapy in AML

Brief Summary: The purpose of this research study is to test the safety and to explore the effectiveness of infusing cytokine- induced memory-like (CIML) natural killer (NK) cells in combination with Interleukin-2 (IL-2) and standard-of-care venetoclax as a treatment for Acute Myeloid Leukemia (AML).Names of the study therapies involved in this study are:Lymphodepleting therapy with Fludarabine and Cyclophosphamide prior to CIML NK cell infusionCIML NK (a cellular therapy)IL-2 (a recombinant, human glycoprotein)Venetoclax (a…

Read more